Review of discount rate in the PBAC Guidelines

Department of Health

25 May 2022 - The Commonwealth has entered into a new Strategic Agreement in relation to reimbursement, health technology assessment and other matters with Medicines Australia acting on behalf of the innovator medicines industry.

The Agreement includes a commitment to seek the advice of the PBAC as to whether the base case discount rate at 3A.1 of the PBAC Guidelines aligns with international best practice.

Read Department of Health press release

Michael Wonder

Posted by:

Michael Wonder